HOVLAND, RAGNAR,HOLMEIDE, ANNE KRISTIN,SKJÆRET, TORE,BRÆNDVANG, MORTEN
申请号:
MYPI 2011005299
公开号:
MY165292A
申请日:
2010.05.07
申请国别(地区):
MY
年份:
2018
代理人:
摘要:
THE PRESENT DISCLOSURE RELATES TO LIPID COMPOUNDS OF THE GENERAL FORMULA (I): R₁-O-C(R₂)(R₃)-X (I) WHEREIN R₁ IS A C₁₀-C₂₂ ALKYL GROUP, A C₁₀-C₂₂ ALKENYL GROUP HAVING 1-6 DOUBLE BONDS, OR A C₁₀-C₂₂ ALKYNYL GROUP HAVING 1-6 TRIPLE BONDS; R₂ AND R₃ ARE THE SAME OR DIFFERENT AND MAY BE CHOSEN FROM DIFFERENT SUSTITUENTS; AND X IS A CARBOXYLIC ACID OR A DERIVATIVE THEREOF, SUCH AS A CARBOXYLIC ESTER, A CARBOXYLIC ANHYDRIDE, A PHOSPHOLIPID, TRIGLYCERIDE, OR A CARBOXAMIDE; OR A PHARMACEUTICALLY ACCEPTABLE SALT, SOLVATE, SOLVATE OF SUCH SALT OR A PRODRUG THEREOF. THE PRESENT DISCLOSURE ALSO RELATES TO PHARMACEUTICAL COMPOSITIONS AND LIPID COMPOSITIONS COMPRISING AT LEAST ONE COMPOUND ACCORDING TO THE PRESENT DISCLOSURE, AND TO SUCH COMPOUNDS FOR USE AS MEDICAMENTS OR FOR USE IN THERAPY, IN PARTICULAR FOR THE TREATMENT OF DISEASES RELATED TO THE CARDIOVASCULAR, METABOLIC, AND INFLAMMATORY DISEASE AREA.